Can you take trimetazidine hydrochloride tablets with warfarin?

The correct generic name for the drug warfarin is warfarin sodium tablets. There is no conflict between the two drugs trimetazidine hydrochloride tablets and warfarin sodium tablets and they can be taken together. Trimetazidine hydrochloride tablets are used for symptomatic treatment of adult patients with stable angina that is not well controlled or tolerated by antianginal therapy. Adverse reactions such as dizziness, headache, abdominal pain, diarrhea, nausea and vomiting, rash, and hives may occur with the use of this drug. It is contraindicated in patients with Parkinson’s syndrome, tremor, restless leg syndrome, and severe renal impairment. Use trimetazidine hydrochloride tablets should be noted that the drug is not used as a symptomatic therapeutic drug in angina attacks and initial treatment of unstable angina or myocardial infarction; this drug should not be used in the first few days of treatment after admission to the hospital; the drug can exacerbate the symptoms of Parkinson’s symptoms, which should be checked regularly. Warfarin sodium tablets are used for the prevention and treatment of deep vein thrombosis, pulmonary embolism, thromboembolism after myocardial infarction, atrial fibrillation, thromboembolism caused by heart valve disease or after prosthetic valve replacement. Use of the drug may cause adverse reactions such as bleeding, nausea and vomiting, diarrhea. The drug is contraindicated in patients who are pregnant, have a tendency and likelihood of bleeding, suffer from diseases such as severe hepatic impairment, uncontrollable hypertension, and those who are allergic to the ingredients of warfarin sodium tablets. It is important to note with warfarin sodium tablets that people suffering from genetic anticoagulant protein C or S deficiency need to be first treated with heparin for 5-7 days, and the starting dose of warfarin sodium should not be more than 5 mg; the use of this drug must be accompanied by careful monitoring of the patient’s clinical condition and his or her INR value. Both of these drugs should be used under the supervision of a physician and should not be used without authorization.